The report provides a detailed analysis essential for establishing a Lemborexant production plant. It encompasses all critical aspects necessary for Lemborexant production, including the cost of Lemborexant production, Lemborexant plant cost, Lemborexant production costs, and the overall Lemborexant production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Lemborexant production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Lemborexant is a prescription medication mainly used in the treatment of insomnia and other sleep-related disorders. It works by blocking certain brain chemicals that promote wakefulness, helping to improve sleep quality and duration. It is used as an active ingredient in prescription medications designed to improve sleep quality without causing significant daytime drowsiness. It finds its application as an oral drug that supports better overall sleep health and reduces the symptoms of chronic sleep disturbances that affect daily functioning and mental well-being. It is also used as a research compound studied for its potential use in managing irregular sleep-wake patterns in people with Alzheimer’s disease and other neurological disorders.
The market for Lemborexant is driven by its application as an oral medication for treating insomnia and sleep-wake disorders, which significantly promotes its demand in the pharmaceutical and healthcare industries. Its application as a medication in improving sleep quality and managing sleep-onset and maintenance insomnia also supports its demand in the medical and healthcare sectors. Its growing demand among sleep medicine specialists and pharmaceutical companies that focus on central nervous system therapies largely contributes to its market growth.
Moreover, its involvement as a preferred alternative to traditional sedative-hypnotic drugs in modern sleep medicine, due to its favourable safety profile and minimal risk of dependence, further fuels its market expansion. Industrial Lemborexant procurement is influenced by factors such as the cost and availability of key raw materials, adherence to pharmaceutical production standards, and compliance with global regulatory guidelines. Additionally, supplier reliability, advancements in drug formulation technology, efficient logistics, and the increasing prevalence of sleep-related disorders worldwide also play a major role in shaping the demand for Lemborexant.
Raw Material for Lemborexant Production
According to the Lemborexant production plant project report, the major raw materials for Lemborexant production include Ethyl Cyanoacetate- (S)-Epichlorohydrin - 2,4-Dimethyl-5-hydroxypyrimidine - 5-Fluoro-2-aminopyridine.
Production Process of Lemborexant
The extensive Lemborexant production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of Lemborexant begins with the reaction of ethyl cyanoacetate and (S)-epichlorohydrin using sodium hexamethyldisilazide to form a cyclopropane intermediate. Then, this intermediate is reduced with sodium borohydride to give a diol compound, which further undergoes a lipase-catalyzed transesterification to produce an acetoxy derivative. Then, the product reacts with 2,4-dimethyl-5-hydroxypyrimidine through a Mitsunobu reaction to form a pyrimidinyl ether, which is oxidized to produce the corresponding carboxylic acid. In the final step, the obtained acid reacts with 5-fluoro-2-aminopyridine using HATU (coupling reagent) and DIPEA (Hünig’s base) in dimethylformamide (DMF) to produce Lemborexant, a dual orexin receptor antagonist used for treating insomnia.
Lemborexant appears as a white to off-white crystalline powder with no distinct odour. It is a dual orexin receptor antagonist used as a sedative-hypnotic drug for the treatment of insomnia. It is stable under normal storage conditions but decomposes upon heating. The compound does not dissolve in water but is freely soluble in organic solvents, such as methanol and ethanol. The molecular formula of lemborexant is C22H20FN3O2, and its molar mass is 377.41 g/mol. The compound has a density of approximately 1.31 g/cm³. It has a melting point in the range of 149–153 degree Celsius. The compound should be handled with care, as improper handling or ingestion may cause drowsiness and other central nervous system effects. Protective measures are recommended during its use.